Venmax Drugs & Pharmaceuticals Ltd
Venmax Drugs & Pharmaceuticals Ltd Live Price Chart
Performance
| Previous Close | ₹ 13.93 |
| High | ₹ 15 |
| Volume | 15582 |
| 52W Range | ₹ 13.52 - ₹ 31.49 |
| Open | ₹ 13.52 |
| Low | ₹ 13.52 |
| Market Cap | ₹ 18.46 Cr |
Venmax Drugs & Pharmaceuticals Ltd Technicals
| 20 Day | ₹ 16.046 |
| 50 Day | ₹ 17.451 |
| 100 Day | ₹ 19.489 |
| 200 Day | ₹ 21.357 |
| 20 Day | ₹ 16.329 |
| 50 Day | ₹ 17.173 |
| 100 Day | ₹ 20.253 |
| 200 Day | ₹ 23.372 |
Venmax Drugs & Pharmaceuticals Ltd Fundamentals
| ROCE | 2.034 |
| P/E Ratio | 73.320 |
| P/B Ratio | 0.970 |
| Industry P/E | 0.970 |
| Debt to Equity | 51.211 |
| ROE | 1.868 |
| EPS | 0.190 |
| Dividend Yield | 0.000 |
| Book Value | 14.368 |
| Face Value | 10.000 |
Venmax Drugs & Pharmaceuticals Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 1.8605 | 0.1986 | 0.4193 | 1.983 | 0.3493107 |
| Total Expenses | 1.8746 | 0.1117 | 0.1936 | 0.1364 | 0.511109 |
| Profit After Tax | -0.0105 | 0.0645 | 0.2256 | 1.8463 | -0.1624628 |
Venmax Drugs & Pharmaceuticals Ltd Shareholding Pattern
| Promoter Holdings | 10.464 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 74.340 % |
| Others - | 15.196 % |
About Venmax Drugs & Pharmaceuticals Ltd
Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998. The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995. It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'. Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs). At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D. Planning to establish a manufacturing UNIT with cGMP facility at Pharma Cluster at Hyderabad, to meet the export demand. ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 44.97 +0.18 (+0.4%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 509.35 +7.45 (+1.48%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 6,870.85 +0.6 (+0.01%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 656.00 +7 (+1.08%) |
| Abbott India Ltd Pharmaceuticals | ₹ 26,000.00 -25.15 (-0.1%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,399.70 -13.45 (-0.95%) |
FAQs on Venmax Drugs & Pharmaceuticals Ltd
1. Can I buy Venmax Drugs & Pharmaceuticals Ltd from PL Capital? ›
2. Does Venmax Drugs & Pharmaceuticals Ltd pay dividends? ›
3. What is the current share price of Venmax Drugs & Pharmaceuticals Ltd ? ›
4. What is the 52-week high and low of Venmax Drugs & Pharmaceuticals Ltd ? ›
Start SIP in Venmax Drugs & Pharmaceuticals Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
